1–2 mg 3–4 times a day, inhalation route preferred over oral route. Salbutamol is a selective β 2-agonist bronchodilator which provides short acting bronchodilation in reversible airways obstruction. Given the adverse side effects and the expense associated with these treatments, bronchodilators are not effective in the routine management of bronchiolitis. Continue typing to refine. In unusual circumstances, such as adults of low body weight, use a starting dosage of 4 mg every 12 hours and progress to 8 mg every 12 hours according to response. BACKGROUND—Salbutamol is frequently used as a bronchodilator for infants who wheeze.Many single dose studies have questioned its effectiveness. Salbutamol should only be used during pregnancy if considered essential by the physician.Potentially serious hypokalaemia may result from beta-2 agonist therapy mainly from parenteral and nebulised administration. Very common and common events were generally determined from clinical trial data. For Child 12–17 years Many single dose studies have questioned its effectiveness. Over 12 years: the minimum starting dose is 2mg three times daily given as 5 ml oral solution. Be cautious when prescribing to children below 2 years of age. Short acting beta agonists for recurrent wheeze in children under 2 years of age Cochrane Database Syst Rev. Further management should be as clinically indicated or as recommended by the national poisons centre, where available.Pharmacotherapeutic group: Selective beta-2-adrenoreceptor agonistsAs a beta-adrenergic stimulant for relief of bronchospasm such as occurs with asthma, bronchitis, emphysema. Peak plasma concentrations occur within one to four hours after oral administration. It is not known whether salbutamol has a harmful effect on the neonate, and so its use should be restricted to situations where it is felt that the expected benefit to the mother is likely to outweigh any potential risk to the neonate.There is no information on the effects of salbutamol on human fertility. For babies and children under 4 years of age, see Section 4.2.

The Medicines Adverse Reactions Committee (MARC) reviewed the safety and efficacy of cough and cold medicines for use in children in December 2007. Date of first authorisation/renewal of the authorisationStart typing to retrieve search suggestions.

Hypersensitivity reactions such as angioedema, urticaria, bronchospasm, hypotension and collapse have rarely been reported. The minimum starting dose is (2mg) one 5 ml spoonful (5ml), 3 or 4 times per day.In elderly patients and patients who are unusually sensitive to this class of medicine treatment may be initiated with (2mg) one 5 ml spoonful (5ml), 3 or 4 times per day.2- 6 years: the minimum starting dose is 1mg as 2.5 ml of oral solution three times daily. : CD001266. She has been prescribed antibiotics and salbutamol both of which Amy ‘hates’. Single dose to be taken in the morning. Concurrent administration of corticosteroids can exaggerate this effect. No. Both unchanged drug and conjugate are excreted primarily in the urine. Patients should receive adequate instruction in correct administration and be warned not to let the solution or mist enter the eye.

For Child 6–11 years. For oral administration. When suggestions are available use up and down arrows to review and ENTER to select. Another anecdote was that an adolescent boy refused to use an inhaler since being seen using an inhaler by his friends would mark him as a weakling. Tips Keep your inhaler with you at all times: make sure you have your inhaler with you at all times so you know where it is when you need it and make sure you have enough salbutamol to last through weekends and holidays. Frequencies are defined as: very common (≥1/10), common (≥1/100 to <1/10), uncommon (≥1/1,000 to <1/100), rare (≥1/10,000 to <1/1,000), very rare (<1/10,000) and not known (cannot be estimated from the available data). This may be increased to four times daily. Ortiz G(1), Menendez R. Author information: (1)Allergy and Asthma Research Center of El Paso, Texas, USA. Serum potassium levels should be monitored. Rare, very rare and unknown events were generally determined from spontaneous data.Hypersensitivity reactions including angioedema, urticaria, bronchospasm, hypotension and collapse.Potentially serious hypokalaemia may result from beta agonist therapy.Cardiac arrhythmias including atrial fibrillation, supraventricular tachycardia and extrasystoles* reported spontaneously in post-marketing data therefore frequency regarded as unknown.Reporting suspected adverse reactions after authorisation of the medicinal product is important. This may be increased to 2mg as 5 ml of oral solution three or four times daily. AIMS—To investigate the response of wheezy infants to salbutamol over an extended time period in order to elucidate either symptomatic relief or a protective effect. It is not known whether salbutamol has a harmful effect on the neonate, and so its use should be restricted to situations where it is felt that the expected benefit to the mother is likely to outweigh any potential risk to the neonate.There is no information on the effects of salbutamol on human fertility. DOI: 10.1002/14651858.CD001266.pub4We use cookies to improve your experience on our site. There is some evidence from post-marketing data and published literature of rare occurrences of myocardial ischaemia associated with salbutamol. Available in boxes containing 20 ampoules.Nebulisers should be used in a well ventilated room as it is usual for some nebulised drug to be released into the local environment.For instructions on the use of this product refer to the Patient Information Leaflet.Dixcart House, Addlestone Road, Bourne Business Park, Addlestone,, KT15 2LE, UKTo bookmark a medicine you must sign up and log in.To view the changes to a medicine you must sign up and log in.